· The best-selling real-time CGM in the world¹ is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app
· New system has the fastest sensor warmup on the market,* with no fingersticks† or scanning required
· Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range²,³
EDINBURGH, Scotland & SAN DIEGO, March 15 (Bernama-BUSINESS WIRE) — DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.
- US to welcome Asian ‘Quad’ back to Washington for a summit
- Global cocaine market hit new record highs: UNODC
- Spain PM Sanchez says Gaza in ‘catastrophic situation of genocide’
- WHO delivers its first medical aid to Gaza since March 2
- Brazilian poultry exports admitted again in 17 countries
- Three Policemen Wounded In Grenade Attack In India
- Lebanese Army Arrested Daesh’s Leader In Lebanon
- S. Korea’s Court Dismissed Warrant To Arrest Ex-President Yoon
- 11 Terrorists, Two Soldiers Killed In Operation In NW Pakistan
- Iran Says Airspace To Remain Closed Until This Afternoon